Fas and Fas ligand in the gut and liver

Zitieren

Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

PINKOSKI, Michael J., Thomas BRUNNER, Douglas R. GREEN, Tesu LIN, 2000. Fas and Fas ligand in the gut and liver. In: American journal of physiology : Gastrointestinal and liver physiology. 278(3), pp. G354-G366

@article{Pinkoski2000ligan-14356, title={Fas and Fas ligand in the gut and liver}, year={2000}, number={3}, volume={278}, journal={American journal of physiology : Gastrointestinal and liver physiology}, pages={G354--G366}, author={Pinkoski, Michael J. and Brunner, Thomas and Green, Douglas R. and Lin, Tesu} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/14356"> <dcterms:abstract xml:lang="eng">Apoptosis (programmed cell death) has been shown to play a major role in development and in the pathogenesis of numerous diseases. A principal mechanism of apoptosis is molecular interaction between surface molecules known as the “death receptors” and their ligands. Perhaps the best-studied death receptor and ligand system is the Fas/Fas ligand (FasL) system, in which FasL, a member of the tumor necrosis factor (TNF) family of death-inducing ligands, signals death through the death receptor Fas, thereby resulting in the apoptotic death of the cell. Numerous cells in the liver and gastrointestinal tract have been shown to express Fas/FasL, and there is a growing body of evidence that the Fas/FasL system plays a major role in the pathogenesis of many liver and gastrointestinal diseases, such as inflammatory bowel disease, graft vs. host disease, and hepatitis. Here we review the Fas/FasL system and the evidence that it is involved in the pathogenesis of liver and gastrointestinal diseases.</dcterms:abstract> <dcterms:title>Fas and Fas ligand in the gut and liver</dcterms:title> <dc:contributor>Lin, Tesu</dc:contributor> <dcterms:issued>2000</dcterms:issued> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:contributor>Green, Douglas R.</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:contributor>Brunner, Thomas</dc:contributor> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T12:52:28Z</dc:date> <dc:creator>Green, Douglas R.</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Brunner, Thomas</dc:creator> <dc:creator>Pinkoski, Michael J.</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-25T12:52:28Z</dcterms:available> <dc:rights>deposit-license</dc:rights> <dc:contributor>Pinkoski, Michael J.</dc:contributor> <dc:language>eng</dc:language> <dc:creator>Lin, Tesu</dc:creator> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14356"/> <dcterms:bibliographicCitation>Publ. in: American journal of physiology : Gastrointestinal and liver physiology ; 278 (2000), 3. - S. G354-G366</dcterms:bibliographicCitation> </rdf:Description> </rdf:RDF>

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto